Technology

Investors are poised to add Establishment Labs Holdings Inc (ESTA) Stock to their long term portfolios

Kevin Freeman

At the time of writing, Establishment Labs Holdings Inc [ESTA] stock is trading at $74.15, up 2.94%. One of the ...

It’s still a bull thesis, just subverted: Catalyst Pharmaceuticals Inc (CPRX)

Kevin Freeman

At the time of writing, Catalyst Pharmaceuticals Inc [CPRX] stock is trading at $24.19, up 0.04%. In order to assess ...

The outlook and analysis of Evolent Health Inc (EVH)’s stock

Kevin Freeman

At the time of writing, Evolent Health Inc [EVH] stock is trading at $4.07, down -1.21%. An important factor to ...

Analysts’ expectations for Knight-Swift Transportation Holdings Inc (KNX) stock: $54.63 price target in 12 months

Kevin Freeman

At the time of writing, Knight-Swift Transportation Holdings Inc [KNX] stock is trading at $53.45, up 0.47%. It is a ...

UMB Financial Corp (UMBF) is expected to grow earnings and revenues in the years ahead

Kevin Freeman

At the time of writing, UMB Financial Corp [UMBF] stock is trading at $119.03, down -0.07%. Until recently, the best ...

Insmed Inc (INSM) stock poised to deliver a potential return of 16.0%

Kevin Freeman

At the time of writing, Insmed Inc [INSM] stock is trading at $200.67, up 1.90%. One of the good ways ...

Ford Motor Co (F) stock expected to loss -13.75% in the coming months

Kevin Freeman

At the time of writing, Ford Motor Co [F] stock is trading at $13.67, up 0.15%. In order to assess ...

Key Takeaways from First Advantage Corp (FA)’s Recent Sales and Margin Figures

Kevin Freeman

At the time of writing, First Advantage Corp [FA] stock is trading at $14.69, down -2.20%. An important factor to ...

Is Perdoceo Education Corporation (PRDO) Stock a Good Buy for Short-term Investors?

Kevin Freeman

At the time of writing, Perdoceo Education Corporation [PRDO] stock is trading at $29.49, up 1.44%. It is a good ...

Growth and Margin Analysis of UroGen Pharma Ltd (URGN)’s Recent Quarter Sales

Kevin Freeman

At the time of writing, UroGen Pharma Ltd [URGN] stock is trading at $23.47, up 2.71%. Until recently, the best ...

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.